Cancer cell metastasis; perspectives from the focal adhesion
Abstract
Keywords
Full Text:
PDFReferences
Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005; 5:591-602. doi: 10.1038/nrc1670 doi: 10.1038/nrc1670
Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol. 2011. doi:10.1038/nrgastro.2011.196
Kakonen SM, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer. 2003; 97:834-9. doi:10.1002/cncr.11132
Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110:673-87. doi: 10.1016/S0092-8674(02)00971-6
Canel M, Serrels A, Frame MC, et al. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013; 126:393-401. doi:10.1242/jcs.100115
Ungefroren H, Sebens S, Seidl D, et al. Interaction of tumor cells with the microenvironment. Cell Commun Signal. 2011; 9:18. doi:10.1186/1478-811X-9-18
Tu Y, Wu S, Shi X, et al. Migfilin and Mig-2 link focal adhesions to Filamin and the actin cytoskeleton and function in cell shape modulation. Cell. 2003; 113:37-47. doi: 10.1016/S0092-8674(03)00163-6
Gkretsi V, Zhang Y, Tu Y, et al. Physical and functional association of migfilin with cell-cell adhesions. J Cell Sci. 2005; 118:697-710. doi: 10.1242/jcs.01638
Zhang Y, Tu, Y, Gkretsi, V, et al. Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration. J Biol Chem. 2006; 281:12397-407. doi: 10.1074/jbc.M512107200
Castellano F, Le Clainche, C, Patin, D, et.al. A WASp–VASP complex regulates actin polymerization at the plasma membrane. EMBO Journal. 2001; 20:5603-14. doi:10.1093/emboj/20.20.5603
Sechi AS, Wehland J. ENA/VASP proteins: multifunctional regulators of actin cytoskeleton dynamics. Front Biosci. 2004; 9:1294-310. doi: 10.2741/1324
Kwiatkowski AV, Gertler FB, Loureiro JJ. Function and regulation of Ena/VASP proteins. Trends Cell Biol. 2003; 13:386-92. doi: 10.1016/S0962-8924(03)00130-2
Papachristou DJ, Gkretsi V, Tu Y, et al. Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcoma. Histopathology. 2007; 51:499-508. doi: 10.1111/j.1365-2559.2007.02791.x
He H, Ding F, Li Y, et al. Migfilin regulates esophageal cancer cell motility through promoting GSK-3beta-mediated degradation of beta-catenin. Mol Cancer Res. 2012; 10:273-81. doi:10.1158/1541-7786
Ou Y, Ma L, Dong L, et al. Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-gamma and STAT3 protein signaling pathways. The Journal of biological chemistry. 2012; 287:32394-405. doi: 10.1074/jbc.M112.393900
Gkretsi V, Papanikolaou V, Zacharia LC, et al. Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer. Anticancer Res. 2013; 33:1977-81.
Davidson B, Holth A, Nguyen MT, et al. Migfilin, alpha-parvin and beta-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases. Gynecol Oncol. 2013;128:364-70. doi: 10.1016/j.ygyno.2012.10.015
Gkretsi V, Bogdanos DP. Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis. Exp Cell Res. 2015. doi:10.1016/j.yexcr.2015.03.002
Maekawa M, Ishizaki T, Boku S, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999; 285:895-8. doi:10.1126/science.285.5429.895
Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4:446-56. doi:10.1038/nrm1128
He H, Ding F, Li S, et al. Expression of migfilin is increased in esophageal cancer and represses the Akt-beta-catenin activation. Am J Cancer Res. 2014; 4:270-8.
Mackinnon AC, Qadota H, Norman KR, et al. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol. 2002; 12:787-97. doi: 10.1016/S0960-9822(02)00810-2
Sepulveda JL, Gkretsi V, Wu C. Assembly and signaling of adhesion complexes. Curr Top Dev Biol. 2005; 68:183-225. doi:10.1016/S0070-2153(05)68007-6
Kato K, Shiozawa T, Mitsushita J, et al. Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas. Hum Pathol. 2004; 35:55-60. doi:10.1016/j.humpath.2003.08.019
Shen Z, Ye Y, Dong L, et al. Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancer. Am J Surg. 2012; 203:222-9. doi:10.1016/j.amjsurg.2011.06.050
An Z, Dobra K, Lock JG, et al. Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration. Int J Cancer. 2010; 127:1999-2008. doi: 10.1002/ijc.25223
Talaat S, Somji S, Toni C, et al. Kindlin-2 expression in arsenite- and cadmium-transformed bladder cancer cell lines and in archival specimens of human bladder cancer. Urology. 2011; 77:1507 e1-7. doi:10.1016/j.urology.2011.02.040
Papachristou DJ, Gkretsi V, Rao UN, et al. Expression of integrin-linked kinase and its binding partners in chondrosarcoma: association with prognostic significance. Eur J Cancer. 2008; 44:2518-25. doi: 10.1016/j.ejca.2008.07.021
Gozgit JM, Pentecost BT, Marconi SA, et al. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer. Mol Cancer Res. 2006; 4:905-13. doi:10.1158/1541-7786.MCR-06-0147
Shi X, Wu C. A suppressive role of mitogen inducible gene-2 in mesenchymal cancer cell invasion. Mol Cancer Res. 2008; 6:715-24. doi: 10.1158/1541-7786.MCR-07-2026.
Xu X, Rongali SC, Miles JP, et al. pat-4/ILK and unc-112/Mig-2 are required for gonad function in Caenorhabditis elegans. Exp Cell Res. 2006; 312:1475-83. doi:10.1016/j.yexcr.2006.01.006
Wu C. The PINCH-ILK-parvin complexes: assembly, functions and regulation. Biochim Biophys Acta. 2004; 1692:55-62. doi:10.1016/j.bbamcr.2004.01.006
Legate KR, Montanez E, Kudlacek O, et al. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006; 7:20-31. doi:10.1038/nrm1789
Wickstrom SA, Lange A, Montanez E, et al. The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! Embo J. 2010; 29:281-91. doi: 10.1038/emboj.2009.376.
Chen K, Tu Y, Zhang Y, et al. PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells. J Biol Chem. 2008; 283:2508-17. doi: 10.1074/jbc.M707307200
Xu Z, Fukuda T, Li Y, et al. Molecular dissection of PINCH-1 reveals a mechanism of coupling and uncoupling of cell shape modulation and survival. J Biol Chem. 2005; 280:27631-7. doi: 10.1074/jbc.M504189200
Dougherty GW, Chopp T, Qi SM, et al. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp Cell Res. 2005; 306:168-79. doi:10.1016/j.yexcr.2005.01.025
Kadrmas JL, Smith MA, Clark KA, et al. The integrin effector PINCH regulates JNK activity and epithelial migration in concert with Ras suppressor 1. J Cell Biol. 2004; 167:1019-24. doi:10.1083/jcb.200408090
Cutler ML, Bassin RH, Zanoni L, et al. Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation. Mol Cell Biol. 1992; 12:3750-6. doi: 10.1128/MCB.12.9.3750
Dougherty GW, Jose C, Gimona M, et al. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells. Eur J Cell Biol. 2008; 87:721-34. doi:10.1016/j.ejcb.2008.02.011
Vasaturo F, Dougherty GW, Cutler ML. Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells. Breast Cancer Res Treat. 2000; 61:69-78. doi: 10.1023/A:1006462323260
Gkretsi V, Bogdanos DP. Elimination of Ras Suppressor-1 from hepatocellular carcinoma cells hinders their in vitro metastatic properties. Anticancer Res. 2015; 35:1509-12.
Giotopoulou N, Valiakou V, Papanikolaou V, et al. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples. Clin Exp Metastasis. 2015; 32:255-65.
Wang Y, Simpson JA, Wluka AE, et al. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study. Arthritis Res Ther. 2009; 11:R31. doi:10.1186/ar2636
Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147:275-92. doi: 10.1016/j.cell.2011.09.024
Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6:449-58. doi:10.1038/nrc1886
Rennebeck G, Martelli M, Kyprianou N. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res. 2005; 65:11230-5. doi: 10.1158/0008-5472.CAN-05-2763
DOI: http://dx.doi.org/10.30564/amor.v1i1.3
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Lefteris C Zacharia, Vasiliki Gkretsi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.